• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsApontis Pharma AG
    Picture of Apontis Pharma AG logo

    APPH — Apontis Pharma AG Share News

    €11.000.000.00%
    de flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapHigh Flyer
    • Market Cap
      €91.63m
    • Enterprise Value
      €80.25m
    • Revenue
      €48.47m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • APPH Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    APPH Dividends
    • Brief: Apontis Pharma And Midas Pharma Announce Development Partnership

      14/12/2021 06:35
    • Brief: Apontis Pharma 9M Adjusted EBITDA Up At EUR 4.4 Mln

      18/11/2021 06:34
    • Brief: Apontis Pharma Announces Market Launch Of New Single Pill

      26/10/2021 06:35
    • Brief: Apontis Pharma Signs New In-Licensing Agreement For A New Single Pill

      14/09/2021 06:34
    • Brief: Apontis Pharma H1 Adj. EBITDA At EUR 2.8 Mln

      11/08/2021 06:40
    • Brief: Apontis EBITDA By End-April Up At EUR 1.6 Million

      20/05/2021 06:34
    Previous12Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.